Deepak Nitrite Q1 profit surges as margin doubles; board clears ₹2,500 crore expansion

Deepak Nitrite Q1 profit surges as margin doubles; board clears ₹2,500 crore expansion

Deepak Nitrite reported a blockbuster June quarter on Tuesday, with profit more than tripling from a year ago as robust operating performance drove a sharp improvement in margins. Alongside the earnings, the company unveiled a major capacity expansion plan, committing ₹2,500 crore towards a new Bisphenol A (BPA) manufacturing project. For the quarter ended June…

Read More
Earnings Central: Airtel beats Street, Morepen hits upper circuit, and Greaves takes a beating

Earnings Central: Airtel beats Street, Morepen hits upper circuit, and Greaves takes a beating

Dear Reader, Tuesday’s earnings cut across sectors, with telecom, FMCG, beauty, e-commerce and auto components all reporting. It was a session that had a bit of everything — record quarters, a 20% upper circuit, upbeat management commentary and one stock that was punished relentlessly. The heavyweights set the tone Bharti Airtel got the ball rolling…

Read More
BSE Q1 profit rises 10% to ₹874 crore; board approves increase in IIBH stake to 20%

BSE Q1 profit rises 10% to ₹874 crore; board approves increase in IIBH stake to 20%

BSE reported a 9.6% sequential increase in consolidated net profit for the June quarter, driven by resilient operating income and higher investment income, while its board approved raising the exchange’s stake in India International Bullion Holding (IIBH) from 3.33% to 20%. Consolidated net profit stood at ₹874 crore for the first quarter of FY27, compared…

Read More
ASK Automotive Q1 profit rises 29% as revenue jumps 52%, but alloy costs squeeze margins

ASK Automotive Q1 profit rises 29% as revenue jumps 52%, but alloy costs squeeze margins

Auto components manufacturer ASK Automotive reported a strong performance for the first quarter of FY27, with revenue growth helping drive a rise in profitability despite pressure on operating margins. The company reported a consolidated net profit of ₹85.1 crore for the quarter ended June 30, 2026, compared with ₹66.1 crore in the corresponding quarter last…

Read More
Metropolis Healthcare Q1 profit rises 26% as TruHealth, Tier III markets gain momentum

Metropolis Healthcare Q1 profit rises 26% as TruHealth, Tier III markets gain momentum

Diagnostic services provider Metropolis Healthcare reported a strong performance for the first quarter of FY27, with growth in patient volumes and diagnostic tests supporting a rise in revenue and profitability. The company reported a consolidated net profit of ₹57 crore for the June quarter, compared with ₹45 crore in the corresponding period last year, marking…

Read More
Bajaj Finance Q1 Business Update: AUM rises 24%, new loans grow 20%

FIIs buy ₹2,446 crore in Indian stocks, but domestic selling and FMCG weakness drag markets lower

Foreign institutional investors (FIIs) remained net buyers of Indian equities on Tuesday, while domestic institutional investors (DIIs) turned net sellers, according to provisional exchange data. FIIs bought equities worth ₹15,630.45 crore and sold shares worth ₹13,183.98 crore, resulting in a net inflow of ₹2,446.47 crore. This was higher than Monday’s net purchase of ₹922.26 crore….

Read More
Market Pulse: Key triggers to watch before the Aug 5 trading session

Market Pulse: Key triggers to watch before the Aug 5 trading session

Companies like Power Grid, Aurobindo Pharma, Biocon, Berger Paints, Whirlpool of India, PB Fintech, Cummins India, Navin Fluorine International, Shilp…Read More 1/5 Earnings Tomorrow: Several companies are set to release financial results on August 5, including Power Grid Corporation, Aurobindo Pharma, Biocon, Berger Paints, Whirlpool of India, PB Fintech (Policybazaar), Cummins India, Navin Fluorine International,…

Read More
Sanofi India Q2 profit rises 20% as diabetes drugs drive growth, margins improve

Sanofi India Q2 profit rises 20% as diabetes drugs drive growth, margins improve

Drug firm Sanofi India Ltd. reported a healthy performance for the second quarter, with profit rising 20% year-on-year as steady growth in its diabetes portfolio and improved operating efficiency helped offset a relatively modest increase in revenue. The pharmaceutical company posted a net profit of ₹83.5 crore for the quarter, up 20.1% from ₹69.5 crore…

Read More